Please login to the form below

Not currently logged in
Email:
Password:

Ariad founder Harvey Berger to retire as CEO and chairman

Effective from December 31 or upon finding of successor

edit-Harvey-BergerAriad Pharmaceuticals founder Harvey J. Berger has announced he will retire as CEO and chairman of the firm.

Berger founded Ariad 23 years ago and has served as its chairman and CEO since 1991, leading the company's growth into an integrated global oncology firm.

Commenting on his time with Ariad, Berger said: “I am proud to have worked with so many incredibly talented employees and together to have achieved so much for cancer patients in need of new treatment options where none exist.

“Ariad has been at the forefront of precision medicine initiatives in cancer, and I expect that the Company will continue to lead the way as new targeted therapies emerge from our drug-discovery platform – built on our computational and structural technologies.”

Under his leadership, Ariad brought Iclusig to the market for the treatment of patients with refractory chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia, approved in the US, EU, Switzerland, Australia, Canada and Israel. 

Marty Duvall, executive VP and chief commercial officer at Ariad, added: “Harvey enthusiastically embraced the evolution of ARIAD into a global commercial company. His pride, satisfaction and commitment to deliver on the vision of transforming patient-lives motivates the commercial team each and every day.”

5th May 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics